Manufacturer's investigation conclusion: a specific cause for the patient¿s sepsis could not be conclusively determined through this evaluation.Furthermore, a direct correlation between heartmate ii lvas (b)(6) and the reported events could not be determined through this investigation multiple attempts were made to obtain additional information regarding the reported events as well as the pump¿s return status; however, no further information was provided by the account and no product has been returned to date.If heartmate ii left ventricular assist system, serial number (b)(6), is returned at a later date, this investigation may be reopened to include the evaluation of the device.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 11apr2017 via customer order.Review of the sterilization and packaging documentation in the device history records found no deviations from manufacturing specifications.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu) is currently available.Section ¿introduction¿ of this document lists adverse events that may be associated with the use of the heartmate ii lvas, including sepsis and death.Although only sepsis was reported by the account, the ifu also lists infection as an adverse event that may be associated with the use of the heartmate ii left ventricular assist system.The ifu also contains information on controlling infection in the patient care and management section.No further information provided.The manufacturer is closing the file on this event.
|